| Revenue | |
| Royalties and license fees | |
| Product sales | 5.76M |
| Research and development | 986K |
| Total revenue | 13.7M |
| Operating costs and expenses | |
| Product costs | 1.95M |
| Customer research and development | |
| Other research and development | |
| Selling, general and administrative | 3.85M |
| Goodwill impairment charge | |
| Restructuring charges | |
| Asset impairment charges | |
| Total operating costs and expenses | 9.57M |
| Income (loss) from operations | 4.13M |
| Other income (loss) | |
| Investment income | 56K |
| Impairment loss on investments | -129K |
| Other income, net | 282K |
| Other income (loss) | 209K |
| Income before income taxes | 4.34M |
| Income tax benefit (provision) | -918K |
| Net income (loss) | 4.1M |
| Basic net income (loss) per common share | 0.28 |
| Diluted net income (loss) per common share | 0.28 |
| Weighted average shares outstanding | |
| Basic | 14.62M |
| Dilutive effect of outstanding stock options and non-vested stock | |
| Diluted | 14.91M |